Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on renal and cardiometabolic function in youth with T1D
NCT05065372Phase 1Recruiting
- Start
- Jul 2022
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of metformin in type 1 diabetes mellitus (T1D) (3 arms). Primary endpoints: Renal Vascular Resistance at 4 months and Glomerular Filtration Rate at 4 months. Started Jul 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05065372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065372.